Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0074
+0.0002 (2.78%)
Mar 5, 2026, 1:53 PM EST
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $8.47 million as of March 5, 2026. Its market cap has decreased by -17.69% in one year.
Market Cap
8.47M
Enterprise Value
11.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.36M to 8.47M, a decrease of -62.09%. That is a compound annual growth rate of -5.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 8.47M | 46.30% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 8.84M |
| NKGen Biotech | 7.84M |
| Brainstorm Cell Therapeutics | 7.72M |
| TRON Group | 7.38M |
| AccuStem Sciences | 7.07M |
| Synlogic | 7.01M |
| Orgenesis | 5.90M |
| BetterLife Pharma | 5.83M |